Paper832907
Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis.
Rietschel ET and 1 other. Infect Immun, 1977. Cited by 70 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis. Papers, record 832907. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/832907
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fever | Major topic |
| Immunization, Passive | Major topic |
| Lipid A | Major topic |
| Lipopolysaccharides | Major topic |
| Shwartzman Phenomenon | Major topic |
| Animals | |
| Dose-Response Relationship, Immunologic | |
| Female | |
| Male | |
| Rabbits | |
| Time Factors |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14,319,407 | MECHANISMS OF ENDOTOXIN TOLERANCE. 3. THE REFRACTORY STATE DURING CONTINUOUS INTRAVENOUS INFUSIONS OF ENDOTOXIN. | J Exp Med | 1965 | https://conductscience.org/library/papers/14319407 | PubMed |
| 2 | 5,804,498 | A new method for the extraction of R lipopolysaccharides. | Eur J Biochem | 1969 | https://conductscience.org/library/papers/5804498 | PubMed |
| 3 | 14,078,002 | MODIFICATION OF HOST RESPONSES TO BACTERIAL ENDOTOXINS. I. SPECIFICITY OF PYROGENIC TOLERANCE AND THE ROLE OF HYPERSENSITIVITY IN PYROGENICITY, LETHALITY, AND SKIN REACTIVITY. | J Exp Med | 1963 | https://conductscience.org/library/papers/14078002 | PubMed |
| 4 | 4,164,248 | Role of antibodies in reactions to gram-negative bacterial endotoxins. | Ann N Y Acad Sci | 1966 | https://conductscience.org/library/papers/4164248 | PubMed |
| 5 | 4,583,074 | Mechanisms of endotoxin tolerance. 8. Specificity of serum transfer. | J Immunol | 1973 | https://conductscience.org/library/papers/4583074 | PubMed |
| 6 | 4,578,307 | Treatment and prevention of intravascular coagulation with antiserum to endotoxin. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4578307 | PubMed |
| 7 | 4,571,328 | The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. | J Exp Med | 1973 | https://conductscience.org/library/papers/4571328 | PubMed |
| 8 | 4,558,866 | Passive immunization against the local Shwartzman reaction. | J Immunol | 1972 | https://conductscience.org/library/papers/4558866 | PubMed |
| 9 | 126,554 | Chemical structure of lipopolysaccharides and endotoxin immunity. | Z Immunitatsforsch Exp Klin Immunol | 1975 | https://conductscience.org/library/papers/126554 | PubMed |
| 10 | 4,725,697 | Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. | Infect Immun | 1973 | https://conductscience.org/library/papers/4725697 | PubMed |
| 11 | 4,960,350 | Relation of structure to function in bacterial O-antigens. VI. Neutralization of endotoxic O-antigens by homologous O-antibody. | Ann N Y Acad Sci | 1966 | https://conductscience.org/library/papers/4960350 | PubMed |
| 12 | 4,944,989 | Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. | Eur J Biochem | 1971 | https://conductscience.org/library/papers/4944989 | PubMed |
| 13 | 4,967,031 | Endotoxin tolerance induced by detoxified endotoxin (endotoxoid). | Proc Soc Exp Biol Med | 1968 | https://conductscience.org/library/papers/4967031 | PubMed |
| 14 | 4,902,894 | Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance. | J Immunol | 1969 | https://conductscience.org/library/papers/4902894 | PubMed |
| 15 | 4,902,179 | Studies on myxovirus pyrogen. (II). Some factors affecting fever tolerance in rabbits. | Biken J | 1969 | https://conductscience.org/library/papers/4902179 | PubMed |
| 16 | 4,927,998 | Interaction of lipopolysaccharides and lipid A with complement. | Eur J Biochem | 1971 | https://conductscience.org/library/papers/4927998 | PubMed |
| 17 | 1,090,853 | Chemical structure and biological activity of endotoxins (lipopolysaccharides) and lipid A. | Naunyn Schmiedebergs Arch Pharmacol | 1975 | https://conductscience.org/library/papers/1090853 | PubMed |
| 18 | 770,165 | Isolation and analysis of the lipid A backbone. Lipid A structure of lipopolysaccharides from various bacterial groups. | Eur J Biochem | 1976 | https://conductscience.org/library/papers/770165 | PubMed |
| 19 | 14,278,229 | MODIFICATION OF HOST RESPONSES TO BACTERIAL ENDOTOXINS. II. PASSIVE TRANSFER OF IMMUNIY TO BACTERIAL ENDOTOXIN WITH FRACTIONS CONTAINING 19S ANTIBODIES. | J Exp Med | 1965 | https://conductscience.org/library/papers/14278229 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23,142,647 | New technologies in developing recombinant attenuated Salmonella vaccine vectors. | Microb Pathog | 2013 | https://conductscience.org/library/papers/23142647 | PubMed |
| 21,632,711 | Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity. | J Immunol | 2011 | https://conductscience.org/library/papers/21632711 | PubMed |
| 9,284,181 | A nonsubstituted primary hydroxyl group in position 6' of free lipid A is required for binding of lipid A monoclonal antibodies. | Infect Immun | 1997 | https://conductscience.org/library/papers/9284181 | PubMed |
| 8,359,907 | A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. | Infect Immun | 1993 | https://conductscience.org/library/papers/8359907 | PubMed |
| 7,131,316 | On the pyrogenic action of intravenous lipid A in rabbits. | J Physiol | 1982 | https://conductscience.org/library/papers/7131316 | PubMed |
| 6,715,042 | Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. | Infect Immun | 1984 | https://conductscience.org/library/papers/6715042 | PubMed |
| 6,409,883 | Spontaneous release of lipopolysaccharide by Pseudomonas aeruginosa. | J Bacteriol | 1983 | https://conductscience.org/library/papers/6409883 | PubMed |
| 6,193,067 | Induction of endotoxin tolerance with nonpyrogenic O-antigenic oligosaccharide-protein conjugates. | Infect Immun | 1983 | https://conductscience.org/library/papers/6193067 | PubMed |
| 4,030,107 | Serum antibodies against common antigens of bacterial lipopolysaccharides in healthy adults and in patients with multiple myeloma. | Infection | 1985 | https://conductscience.org/library/papers/4030107 | PubMed |
| 3,666,956 | The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. | Infect Immun | 1987 | https://conductscience.org/library/papers/3666956 | PubMed |
| 3,657,701 | A direct enzyme-linked immunosorbent assay (ELISA) for antibodies to enterobacterial Re core glycolipid and lipid A. Results in healthy subjects and in patients infected by gram-negative bacteria. | Med Microbiol Immunol | 1987 | https://conductscience.org/library/papers/3657701 | PubMed |
| 3,296,482 | Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis. | World J Surg | 1987 | https://conductscience.org/library/papers/3296482 | PubMed |
| 3,293,850 | Monoclonal antibodies to salmonella lipopolysaccharide: functional analysis of anti-lipid A antibodies. | Clin Exp Immunol | 1988 | https://conductscience.org/library/papers/3293850 | PubMed |
| 2,867,028 | Inhibition of lipopolysaccharide mitogenicity with characterized anti-lipid A monoclonal antibodies. | Immunology | 1985 | https://conductscience.org/library/papers/2867028 | PubMed |
| 2,581,900 | Characterization of two different antibody specificities recognizing distinct antigenic determinants in free lipid A of Escherichia coli. | Infect Immun | 1985 | https://conductscience.org/library/papers/2581900 | PubMed |
| 2,437,155 | Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides. | J Clin Invest | 1987 | https://conductscience.org/library/papers/2437155 | PubMed |
| 1,816,107 | Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides. | Infection | 1991 | https://conductscience.org/library/papers/1816107 | PubMed |
| 1,639,498 | Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures. | Infect Immun | 1992 | https://conductscience.org/library/papers/1639498 | PubMed |
| 1,375,194 | Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. | Infect Immun | 1992 | https://conductscience.org/library/papers/1375194 | PubMed |
| 732,882 | Chemical structure and biological activities of lipid A's from various bacterial families. | Naturwissenschaften | 1978 | https://conductscience.org/library/papers/732882 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/832907
GET https://conductscience.org/api/papers/v1/832907/authors